DMAAU
Drugs Made In-U·NASDAQ
--
--(--)
--
--(--)
DMAAU fundamentals
Drugs Made In-U (DMAAU) released its earnings on Nov 18, 2025: revenue was -- (YoY 0.00%), beat estimates; EPS was 0.0652 (YoY +485.80%), missed estimates.
Revenue / YoY
--
0.00%
EPS / YoY
0.0652
+485.80%
Report date
Nov 18, 2025
EPS
Revenue
Revenue & Expenses
Key Indicators
Drugs Made In-U (DMAAU) key financial stats and ratios, covering profitability, financial health, and leverage.
Drugs Made In-U (DMAAU)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Drugs Made In-U (DMAAU)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Drugs Made In-U (DMAAU)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Drugs Made In-U (DMAAU) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Drugs Made In-U (DMAAU) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What does Drugs Made In-U do and what are its main business segments?What is Drugs Made In-U's gross profit margin?What were the key takeaways from Drugs Made In-U’s earnings call?What is Drugs Made In-U's latest dividend and current dividend yield?What is the market's earnings forecast for Drugs Made In-U next quarter?What factors drove the changes in Drugs Made In-U's revenue and profit?What is the revenue and EPS growth rate for Drugs Made In-U year over year?What guidance did Drugs Made In-U's management provide for the next earnings period?
